InsidersTradesSigma
Follow the 리가켐바이오 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 리가켐바이오 has published 9 reports. Market capitalisation: €3,469bn. The latest transaction was reported on 24 July 2026 (Purchase). Among the most active insiders: PANORIONCORP.LIMITED. All data is accessible without an account.
Analysts rate 리가켐바이오 Buy (bullish), based on 6 analysts. Average price target: ₩211,667.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
LigaChemBio es una empresa especializada en el sector de la salud y farmacéutico, cotizada en el mercado XKRX. Se enfoca en el desarrollo de soluciones innovadoras para el tratamiento de enfermedades.